Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study
- 476 Downloads
Atrial fibrillation (AF) accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. Little is known about the characteristics of current use of cardioversion (CV) and its success rates in clinical practice in Germany.
As part of the international RHYTHM-AF Study, 655 consecutive patients with documented AF (mean age 68.3 ± 10.5 years, 64.9 % males) who were considered candidates for CV were prospectively enrolled in 22 German hospitals (21 academic/teaching and 1 non-teaching). CV was considered successful if sinus rhythm or atrial rhythm was obtained within 1 day after start of pharmacological CV (PCV) or if sinus rhythm was achieved and maintained for at least 10 min after electrical CV (ECV).
Patients with AF considered for CV had ECG in 94.4 %, Holter ECG in 25.8 %, and transesophageal echocardiography (TEE) in 73.1 % of cases. They underwent ECV (after mean 16 h, range 4–48), in 65.3 % and PCV in 6.7 % of patients (amiodarone in 47.7 %, flecainide in 27.3 %, propafenone in 2.3 %) as first CV procedure. No CV was performed in 27.9 %, mainly due to spontaneous CV or pathologic TEE. Primary success rates were 86.7 % for electrical CV and 54.5 % for pharmacological CV. More patients in the ECV group compared to the PCV group received oral anticoagulation at discharge (79.2 vs. 59.1 %, p < 0.001), and at 60 days (77.5 vs. 56.8 %, p < 0.001). Further, at 60 days the proportion of patients in sinus rhythm was not different between groups (ECV 76.8 % vs. PCV 77.3 %).
In large academic centres in Germany, the preferred CV method is electrical, mainly due to its easy access and to its higher success rate for the initial restoration of sinus rhythm. Considering the limitations of the open-label, non-randomised study design, overall short-term success rates appeared higher after ECV compared to PCV during hospitalisation, but not after 60 days.
KeywordsAtrial fibrillation Observational Registry Pharmacological conversion Electrical conversion Outcomes
The study was financially supported by Merck & Co., Inc., and its subsidiaries. The Institut für Herzinfarktforschung Ludwigshafen received grant/research support from Merck to collect and analyse the data of this study.
Conflict of interest
A.K.G. has been a consultant for and served on the speakers’ bureau of MSD. D.P. and T.L. have provided consultancy for MSD and other manufacturers of cardiovascular drugs. W.S. and G.M. are full-time employees of MSD Germany. A.B. states that there is no conflict of interest.
- 1.Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al (2006) ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48:e149–e246CrossRefGoogle Scholar
- 10.Bosch RF, Kirch W, Theuer JD, Pittrow D, Kohlhaussen A, Willich SN et al (2012) Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: Prospective non-interventional study. Int J Cardiol doi: 10.1016/j.ijcard.2012.03.053 (online first)
- 19.Kleemann T, Becker T, Strauss M, Schneider S, Seidl K (2009) Prevalence of left atrial thrombus and dense spontaneous echo contrast in patients with short-term atrial fibrillation <48 hours undergoing cardioversion: value of transesophageal echocardiography to guide cardioversion. J Am Soc Echocardiogr 22:1403–1408PubMedCrossRefGoogle Scholar
- 20.Seidl K, Rameken M, Drogemuller A, Vater M, Brandt A, Schwacke H et al (2002) Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol 39:1436–1442PubMedCrossRefGoogle Scholar
- 22.Hendriks JM, de Wit R, Crijns HJ, Vrijhoef HJ, Prins MH, Pisters R et al (2012) Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J 33:2692–2699PubMedCrossRefGoogle Scholar